Profound Medical Corp.
PRN.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.71M | 2.83M | 2.44M | 1.38M | 1.20M |
| Total Other Revenue | 8.66M | 8.56M | 8.20M | 7.56M | 6.64M |
| Total Revenue | 11.37M | 11.39M | 10.21M | 8.51M | 7.41M |
| Cost of Revenue | 3.57M | 3.79M | 3.59M | 3.43M | 3.07M |
| Gross Profit | 7.80M | 7.60M | 6.62M | 5.08M | 4.34M |
| SG&A Expenses | 30.78M | 26.51M | 23.09M | 22.29M | 19.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.09M | 48.15M | 43.68M | 42.04M | 38.51M |
| Operating Income | -42.72M | -36.76M | -33.47M | -33.52M | -31.10M |
| Income Before Tax | -41.07M | -32.34M | -28.20M | -31.52M | -27.88M |
| Income Tax Expenses | 44.00K | -1.00K | -2.00K | 7.00K | -152.00K |
| Earnings from Continuing Operations | -41.12 | -32.34 | -28.20 | -31.53 | -27.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.12M | -32.34M | -28.20M | -31.53M | -27.73M |
| EBIT | -42.72M | -36.76M | -33.47M | -33.52M | -31.10M |
| EBITDA | -41.87M | -35.82M | -32.44M | -32.63M | -30.14M |
| EPS Basic | -1.47 | -1.23 | -1.14 | -1.34 | -1.22 |
| Normalized Basic EPS | -0.92 | -0.77 | -0.71 | -0.84 | -0.77 |
| EPS Diluted | -1.47 | -1.23 | -1.14 | -1.34 | -1.22 |
| Normalized Diluted EPS | -0.92 | -0.77 | -0.71 | -0.84 | -0.77 |
| Average Basic Shares Outstanding | 110.40M | 104.79M | 99.04M | 94.64M | 91.38M |
| Average Diluted Shares Outstanding | 110.40M | 104.79M | 99.04M | 94.64M | 91.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |